Table 3 Comparison of cumulative disease activity, treatment and persistence with therapy between OHSI and paired controls
Cases (N = 12) | Controls (N = 48) | p | |
|---|---|---|---|
DAS28 | 3.1 (2.5-3.5) | 2.6 (2.3-3.2) | 0.09 |
N° (%) of patients who achieved a 1st SR | 8 (66.7) | 40 (83.3) | 0.23 |
Months in 1st SR | 12 (0–28.5) | 27 (10-41.5) | 0.12 |
N° of flares/patient | 6 (3.5-9.5) | 3 (1-6) | 0.03 |
% of follow-up in remission status | 50.7 (19-65.6) | 71.4 (50.3-80.6) | 0.02 |
N° DMARD/patient | 1.5 (1-3) | 2 (1-2.5) | 0.88 |
N° of patients with corticosteroids | 11 (91.7) | 42 (87.5) | 1 |
Dose of corticosteroids | 7.5 (5-7.5) | 5 (5-7.5) | 0.32 |
N° (%) of patients persistent | 2 (16.7) | 24 (50) | 0.05 |
N° (%) of patients always persistent | 2 (16.7) | 22 (45.8) | 0.06 |
% of patients follow-up persistent with therapy | 75 (50–82.5) | 92.5 (75–100) | 0.04 |